| GA20526-5mg |
|
339990-02-2 |
Acetyl-(Pro¹⁸,Asp²¹)-Amyloid β-Protein (17-21) amide
|
0 |
C35H46N6O8 |
|
|
|
| GA20525-1mg |
|
461640-33-5 |
Acetyl-(N-Me-Leu¹⁷,N-Me-Phe¹⁹)-Amyloid β-Protein (16-20) amide
|
0 |
C39H59N7O6 |
|
|
|
| GA20525-005mg |
|
461640-33-5 |
Acetyl-(N-Me-Leu¹⁷,N-Me-Phe¹⁹)-Amyloid β-Protein (16-20) amide
|
0 |
C39H59N7O6 |
|
|
|
| GA20524-5mg |
|
155709-24-3 |
Acetyl-(Leu²⁸·³¹)-Neuropeptide Y (24-36)
|
0 |
C81H131N27O19 |
|
|
|
| GA20524-1mg |
|
155709-24-3 |
Acetyl-(Leu²⁸·³¹)-Neuropeptide Y (24-36)
|
0 |
C81H131N27O19 |
|
|
|
| GA20523-5mg |
|
143037-33-6 |
Acetyl-(D-Trp¹⁶)-Endothelin-1 (16-21)
|
0 |
C46H62N8O10 |
|
|
|
| GA20523-1mg |
|
143037-33-6 |
Acetyl-(D-Trp¹⁶)-Endothelin-1 (16-21)
|
0 |
C46H62N8O10 |
|
|
|
| GA20522-1mg |
|
202463-00-1 |
Acetyl-(D-Phe²,Lys¹⁵,Arg¹⁶,Leu²⁷)-VIP (1-7)-GRF (8-27)
|
0 |
C150H246N44O38 |
|
|
|
| GA20522-005mg |
|
202463-00-1 |
Acetyl-(D-Phe²,Lys¹⁵,Arg¹⁶,Leu²⁷)-VIP (1-7)-GRF (8-27)
|
0 |
C150H246N44O38 |
|
|
|
| GA20521-1mg |
|
93942-91-7 |
Acetyl-(D-Arg²)-GRF (1-29) amide (human)
|
0 |
C154H255N47O43S |
|
|
|
| GA20521-005mg |
|
93942-91-7 |
Acetyl-(D-Arg²)-GRF (1-29) amide (human)
|
0 |
C154H255N47O43S |
|
|
|
| GA20520-5mg |
|
819048-44-7 |
Acetyl-(D-Arg¹⁰,Cys¹¹,D-Phe¹⁴,Cys¹⁷)-β-MSH (10-17) amide
|
0 |
C51H70N18O11S2 |
|
|
|
| GA20520-1mg |
|
819048-44-7 |
Acetyl-(D-Arg¹⁰,Cys¹¹,D-Phe¹⁴,Cys¹⁷)-β-MSH (10-17) amide
|
0 |
C51H70N18O11S2 |
|
|
|
| GA20519-25g |
|
17916-88-0 |
|
0 |
C7H13NO3 |
|
|
|
| GA20519-5g |
|
17916-88-0 |
|
0 |
C7H13NO3 |
|
|
|
| GA20518-5g |
|
19764-32-0 |
|
0 |
C11H13NO4 |
|
|
|
| GA20518-1g |
|
19764-32-0 |
|
0 |
C11H13NO4 |
|
|
|
| GA20517-5g |
|
59785-68-1 |
|
0 |
C7H11NO3 |
|
|
|
| GA20517-1g |
|
59785-68-1 |
|
0 |
C7H11NO3 |
|
|
|
| GA20516-25g |
|
21156-62-7 |
|
0 |
C12H15NO3 |
|
|
|
